Toward the end of last year, we entered into a collaboration with AstraZeneca to deliver an AI designed antibody ... We are ...

Datopotamab deruxtecan new BLA submitted for accelerated approval in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer AstraZeneca and Daiichi Sankyo's new ...

IonQ aims to lead the quantum networking market with two key milestones achieved this year. Read more about IONQ stock here.

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

When it comes to pre-revenue biotechs, it's often a struggle to build an investment thesis beyond "if the medicine works, the ...

Turning now to our balance sheet and cash flow. As of September 30 ... from being optimally effective in treating these cancers. This, coupled with the fact that most anticancer therapies are not ...

Traders are looking to fresh US consumer price data, due on Wednesday, for a read on the health of the economy.

The USD Index needs to break and hold above 105.70 for a decisive move toward 106.13 and 106.30, UOB Global Economics & Markets Research said. Descending trendline resistance connecting the highs of ...

The FTSE 100 and European stocks headed higher on Monday, after three weeks in the red, as the dust settles on chancellor Rachel Reeves' first UK budget and the US election. Last week, both the Bank ...

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...